Tyrosine-Based Monitoring of Glucocorticoid Therapy of Systemic Lupus Erythematosus

QR Code

Tyrosine-Based Monitoring of Glucocorticoid Therapy of Systemic Lupus Erythematosus

None

Saved in:

Bibliographic Details
Main Author:	Rass, I. T.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/33007
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2020-03-01)

Cytokines and Systemic Lupus Erythematosus
by: Urra, Jose Miguel, et al.
Published: (2012)

Infections and Systemic Lupus Erythematosus
by: Arce-Salinas, C. Alejandro, et al.
Published: (2012)

Effects of glucocorticoid withdrawal on relapse risk in systemic lupus erythematosus: A systematic review and meta-analysis
by: Sicheng Huang, et al.
Published: (2025-07-01)

Genetics and Epigenetic in Systemic Lupus Erythematosus
by: AlFadhli, Suad M.
Published: (2012)

Interferon and Apoptosis in Systemic Lupus Erythematosus
by: Clark, Daniel N., et al.
Published: (2012)

Kidney Manifestation of Systemic Lupus Erythematosus
by: Habhab, Wael
Published: (2012)

Cardiovascular Involvement in Systemic Lupus Erythematosus
by: Abdulaziz, Sultana, et al.
Published: (2012)

Pulmonary Manifestations of Systemic Lupus Erythematosus
by: Gari, Abdul Ghafoor, et al.
Published: (2012)

Haematological Manifestations in Systemic Lupus Erythematosus
by: Janoudi, Nahid, et al.
Published: (2012)

Economic Evaluations in Systemic Lupus Erythematosus
by: Quintana, Gerardo, et al.
Published: (2011)

Integral Treatment of Systemic Lupus Erythematosus
by: Parrondo, Raquel Ramírez
Published: (2011)

The Pathophysiology of Systemic Lupus Erythematosus and the Nervous System
by: Oster, Joel M.
Published: (2012)

Lymphoproliferative Disorders in Patients with Systemic Lupus Erythematosus
by: Panizo, Carlos, et al.
Published: (2012)

Neonatal Lupus Erythematosus (NLE)
by: Al-Osaimi, Hanan, et al.
Published: (2012)

Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)
by: E. V. Ermolaeva, et al.
Published: (2024-02-01)

Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality?
by: S. K. Soloviev, et al.
Published: (2022-02-01)

The Emerging Role of Monoclonal Antibodies in the Treatmentof Systemic Lupus Erythematosus
by: Robak, Ewa, et al.
Published: (2011)

Objective assessment of the damaging effect of glucocorticoids (toxicity index) in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2021-12-01)

Anti-Tumour Necrosis Factor-α Induced Systemic Lupus Erythematosus
by: Almoallim, Hani, et al.
Published: (2012)

Tyrosine hydroxylase of the brain and it’s regulation by glucocorticoids
by: E. V. Sukhareva, et al.
Published: (2016-05-01)

Regulation of Nucleic Acid Sensing Toll-Like Receptors in Systemic Lupus Erythematosus
by: Leifer, Cynthia A., et al.
Published: (2012)

A Rabbit Model of Systemic Lupus Erythematosus, Useful for Studies of Neuropsychiatric SLE
by: Mage, Rose G., et al.
Published: (2012)

Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
by: L A Archakova, et al.
Published: (2004-02-01)

Immunotargets and Therapy for Systemic Lupus Erythematosus
by: Mok CC
Published: (2025-06-01)

Autologous Peripheral Blood Purified Stem Cells Transplantation for Treatment of Systemic Lupus Erythematosus
by: Sun, Ledong, et al.
Published: (2012)

Antiphospholipid Antibodies and Their Association with Atherosclerotic Changes in Patients with Systemic Lupus Erythematosus – Review of Literature and Own Experiences
by: Fischer, Katarzyna, et al.
Published: (2012)

Real-world effectiveness of belimumab and anifrolumab in systemic lupus erythematosus: comparable trends in disease activity and glucocorticoid reduction
by: Ryota Sato, et al.
Published: (2025-07-01)

Systemic lupus erythematosus: new horizons for diagnosis and therapy
by: S. K. Solovyev, et al.
Published: (2020-02-01)

The Glucocorticoid Receptor in Retroviral Infection
by: Fouty, Brian, et al.
Published: (2011)

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-10-01)

DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2016-07-01)

Modulation of active oxygen forms production by circulating phagocytes and clinical efficacy of glucocorticoid treatment in patients with systemic lupus erythematosus
by: N. V. Romanova, et al.
Published: (2005-02-01)

Targeting Tyrosine Hydroxylase to Improve Bradykinesia
by: Salvatore, Michael F.
Published: (2012)

Systemic lupus erythematosus and gestation. Part I. Gestation influence on activity of systemic lupus erythematosus
by: N M Kosheleva, et al.
Published: (2005-10-01)

Emergencies in systemic lupus erythematosus
by: Senem Tekeoğlu, et al.
Published: (2025-07-01)

OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: N V Seredavkina, et al.
Published: (2009-12-01)

Aspergillosis in systemic lupus erythematosus
by: T. M. Reshetnyak, et al.
Published: (2016-05-01)

Non-Conventional MRI Techniques in Neurophychiatric Systemic Lupus Erythematosus (NPSLE): Emerging Tools to Elucidate the Pathophysiology and Aid the Diagnosis and Management
by: Papadaki, Efrosini Z., et al.
Published: (2012)

Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01)